根据名称进行药物检索

Azuphen MB与结晶尿

Azuphen MB与结晶尿安全配伍检测的结果。

检测结果:

Azuphen MB <> 结晶尿

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

使用乌洛托品的盐类(即乌洛托品马尿酸盐或酸盐)，但是没有基础，是禁忌的患者中的严重肾损伤或脱水。乌洛托品是排泄肾脏浓缩的尿液。在患者低尿出，盐可以沉淀物并导致結晶尿.

来源

Klinge E, Mannisto P, Mantyla R, Lamminsivu U, Ottoila P "Pharmacokinetics of methenamine in healthy volunteers." J Antimicrob Chemother 9 (1982): 209-16
Australian Drug Evaluation Committee "Adverse effects of drugs commonly used in the treatment of urinary tract infection." Med J Aust 1 (1972): 435-8
"Product Information. Hiprex (methenamine)." Hoechst Marion-Roussel Inc, Kansas City, MO.
American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association; (1994):
"Product Information. Mandelamine (methenamine)." Parke-Davis, Morris Plains, NJ.
Gleckman R, Alvarez S, Joubert D, Matthews S "Drug therapy reviews: methenamine mandelate and methenamine hippurate." Am J Hosp Pharm 36 (1979): 1509-12

Azuphen MB

非专利名称: hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate

品牌: Azuphen MB, Hyolev MB, Phosphasal, UR N-C, Uramit MB, Urelle, Uribel, Urimar-T, Urin D/S, Uro-L, Ustell, Utira-C, Uro-MP, Vilamit MB, Vilevev MB, UR N-C, Urelle, Uretron D/S, Urin DS, Uro-458, UroAv-81, UroAv-B, Uticap, Utrona-C

同义词: 无

Azuphen MB是什么？